John P. Cunha, DO, FACOEP
John P. Cunha, DO, is a U.S. board-certified Emergency Medicine Physician. Dr. Cunha's educational background includes a BS in Biology from Rutgers, the State University of New Jersey, and a DO from the Kansas City University of Medicine and Biosciences in Kansas City, MO. He completed residency training in Emergency Medicine at Newark Beth Israel Medical Center in Newark, New Jersey.
William C. Shiel Jr., MD, FACP, FACR
Dr. Shiel received a Bachelor of Science degree with honors from the University of Notre Dame. There he was involved in research in radiation biology and received the Huisking Scholarship. After graduating from St. Louis University School of Medicine, he completed his Internal Medicine residency and Rheumatology fellowship at the University of California, Irvine. He is board-certified in Internal Medicine and Rheumatology.
In this Article
- What is melioidosis? What causes melioidosis?
- Where does melioidosis occur?
- What are symptoms of melioidosis?
- How is melioidosis diagnosed?
- How is melioidosis treated?
- Can melioidosis be prevented?
- What is the prognosis for melioidosis?
- Melioidosis At A Glance
What is the prognosis for melioidosis?
Untreated, melioidosis is fatal. When treated with antibiotics, severe forms of the illness have a 50% chance of recovery, but overall the mortality rate is 40%.
- Melioidosis is an infectious disease caused by a bacterium, Burkholderia pseudomallei.
- Melioidosis infection commonly involves the lungs.
- Melioidosis is diagnosed with the help of blood, urine, sputum, or skin-lesion testing.
- Melioidosis is treated with antibiotics.
- The overall mortality rate is 40%.
U.S. Centers for Disease Control and Prevention
Last Editorial Review: 4/1/2008
Find out what women really need.